Nolan Campbell

Nolan Campbell Email and Phone Number

J&J Medical Director | Leader of Teams and Evidence Generation | Designer of Studies and Analyses | Experience in Medical and Clinical Development | Focus in Neurology, Neuroimmunology, and Neuromuscular Disease @ Johnson & Johnson
Nolan Campbell's Location
Greater Boston, United States, United States
Nolan Campbell's Contact Details

Nolan Campbell work email

Nolan Campbell personal email

n/a
About Nolan Campbell

I am a Medical Director and leader of high-talent teams, focused in neurology, neuroimmunology, and neuromuscular disease. Guiding my career decisions is the belief that rigorous science can improve the art of medical practice. I am dedicated to work that can make a difference in the lives of patients with devastating diseases. Toward that aim, I endeavor to gain expertise in evidence generation in both medical and clinical development aspects of pharma, and I work to develop teams that share a similar vision. My home is in northeastern Pennsylvania, but for the past 10 years I have supported research for fortune 500 companies in Boston, MA and Horsham, PA. I am flexible to fully remote, hybrid, or on-site working styles and traveling for work as needed. I have gained experience and had success with each.In considering my career path, I intend to maintain my anchor in leading science to improve the art of medicine. I will value and prioritize work with potential to make an impact on patients’ lives over title, salary, or a specific indication. Quality data generation efforts are necessary in both the development of new treatments and in improving the use of those already on market. Thus, I am open to opportunities within clinical development, medical, or other related functions as the problem demands. Select accomplishments:• Executed 3 clinical studies to validate smartphone-based digital measures, resulting in inclusion in 1 Phase II clinical trial and in the clinical development plans for 3 assets.• Advanced precision medicine methodology of 2-stage models of heterogeneous treatment effects to predict patients who would optimally benefit from initiating higher efficacy multiple sclerosis therapy.• Advanced 4 analytical workstreams, demonstrating digital solutions can improve on gold standard measures with realized improvements on the SDMT, 9-HPT, T25FW, and myotonia grip relaxation test.• Leveraged real-world and trial data on 3 occasions to gain approval for changes to EMA SmPC, including indication expansion and edits to warnings and precautions section. Also authored regulatory submissions and response documents for each.• Designed and led execution for Phase IIIB, randomized clinical trial published in top-tier journal with resulting changes to EMA SmPC.Core competencies:Clinical study design, Clinical trials, Real-world evidence, Advisory boards, Medical affairs, Clinical development, Team management, Product strategy, Strategic partnerships, Digital health technology, Research and development, Medical communications

Nolan Campbell's Current Company Details
Johnson & Johnson

Johnson & Johnson

View
J&J Medical Director | Leader of Teams and Evidence Generation | Designer of Studies and Analyses | Experience in Medical and Clinical Development | Focus in Neurology, Neuroimmunology, and Neuromuscular Disease
Nolan Campbell Work Experience Details
  • Johnson & Johnson
    Medical Director
    Johnson & Johnson Jan 2024 - Present
    New Brunswick, Nj, Us
    Medical lead responsible for US launches of nipocalimab across neuroimmunology indications
  • Biogen Digital Health
    Senior Director And Head Of Science For Multiple Sclerosis And Neuromuscular Disorders
    Biogen Digital Health Oct 2022 - Oct 2023
    Reporting to the Science Vice President of Biogen Digital Health, developed strategy and tactics and defined value proposition for advancing precision medicine and digital biomarker research in support of medical and clinical development priorities. Initially focused on multiple sclerosis and expanded to include neuromuscular indications. Led geographically distributed program team comprised of scientists, data scientists, statisticians, and others, overseeing three direct reports and managing a $2M to $3M annual budget.• Executed three clinical studies to establish the reliability, construct validity, and sensitivity of smartphone-based digital measures, resulting in inclusion in one Phase II clinical trial and in the clinical development plans for three assets.• Leveraged real-world research network to advance precision medicine methodology of two-stage models of heterogeneous treatment effects to predict patients who would optimally benefit from initiating higher efficacy multiple sclerosis therapy (two congress presentations and manuscript in development).• Advanced four analytical workstreams, demonstrating digital solutions can improve on gold standard measures with realized improvements on the symbol digit modalities test, 9-hole peg test, timed 25-foot walk, and myotonia grip relaxation test (four congress presentations and manuscript in development).• Promoted after one year, doubling scope of remit, in recognition of exceptional vision, clearly defined value propositions, and exemplary collaboration with R&D.
  • Biogen Digital Health
    Director And Head Of Science For Multiple Sclerosis
    Biogen Digital Health Sep 2021 - Oct 2022
    Reporting to the Science Vice President of Biogen Digital Health, developed strategy and tactics and defined value proposition for advancing precision medicine and digital biomarker research in support of medical and clinical development priorities. Initially focused on multiple sclerosis and expanded to include neuromuscular indications. Led geographically distributed program team comprised of scientists, data scientists, statisticians, and others, overseeing three direct reports and managing a $2M to $3M annual budget.• Executed three clinical studies to establish the reliability, construct validity, and sensitivity of smartphone-based digital measures, resulting in inclusion in one Phase II clinical trial and in the clinical development plans for three assets.• Leveraged real-world research network to advance precision medicine methodology of two-stage models of heterogeneous treatment effects to predict patients who would optimally benefit from initiating higher efficacy multiple sclerosis therapy (two congress presentations and manuscript in development).• Advanced four analytical workstreams, demonstrating digital solutions can improve on gold standard measures with realized improvements on the symbol digit modalities test, 9-hole peg test, timed 25-foot walk, and myotonia grip relaxation test (four congress presentations and manuscript in development).• Promoted after one year, doubling scope of remit, in recognition of exceptional vision, clearly defined value propositions, and exemplary collaboration with R&D.
  • Biogen
    Medical Director, Tysabri
    Biogen Oct 2016 - Sep 2021
    Cambridge, Ma, Us
    Initially hired to lead analyses and execution of Tysabri observational program and Phase III Ascend extension study. Promoted in less than three years to lead the global medical team data generation planning, prioritization, and execution. Oversaw field medical communication and training related to data generation efforts.• Leveraged real-world and existing trial data on three occasions to gain approval for changes to EMA Summary of Product Characteristics, including indication expansion and edits to warnings and precautions section. Also authored regulatory submissions and response documents for each.• Designed and led execution for Phase IIIB, randomized clinical trial published in top-tier journal with resulting changes to EMA Summary of Product Characteristics.• Chaired steering committee meetings and ran advisory boards to evolve evidence generation strategies for Nova, Ascend, Top, and PML risk estimation workstreams, all resulting in high-priority manuscripts.• Represented the medical department on the Safety Surveillance Team and Research & Development Program Team.
  • Biogen
    Medical Research Scientist, Tysabri, Plegridy, Avonex, Ms Franchise
    Biogen Oct 2014 - Oct 2016
    Cambridge, Ma, Us
    Assessed feasibility and strategic alignment for investigator-initiated trials (IITs) and Phase IV trials. Created evidence generation plans, performed gap analyses, and defined areas of research interest. Chaired Clinical Trial Review Committee meetings and documented all recommendations and decisions.• Recognized for significantly improving due diligence assessment process on incoming IITs.• Authored regulatory responses to an article 20 procedure with a successful outcome, a contribution beyond the scope of the position.
  • Biogen
    Scientific Writer
    Biogen Jun 2013 - Oct 2014
    Cambridge, Ma, Us
    Gathered resources for, and wrote, first drafts of high-priority publications (abstracts, posters, and manuscripts). Liaised with statisticians, medical directors, and key opinion leaders (KOLs) to ensure accuracy of deliverables. Attended congresses to assist with medical competitive intelligence and communication objectives.• Assigned to all high-priority manuscripts at request of the medical director team and in recognition for quality of writing.• Contributed to science by authoring manuscript, an exceptional endeavor for the role.
  • Mit
    Postdoctoral Associate
    Mit Sep 2010 - Jun 2013
    Cambridge, Ma, Us
    1) Designed and tested novel strategies for genetic manipulation using coincident detection of neuronal activity and light, 2) Explored the circuitry underlying cognitive flexibility impairments in mouse models of obsessive-compulsive and autism spectrum disorders.
  • Uc San Diego
    Graduate Student Researcher
    Uc San Diego Aug 2003 - Jul 2010
    La Jolla, Ca, Us
    Demonstrated the role of nicotinic acetylcholine receptors on new neuron generation in the adult brain and examined the underlying mechanisms.
  • Umkc
    Undergraduate Researcher
    Umkc Jan 2000 - Aug 2003
    Kansas City, Mo, Us
    Characterized a novel class of spontaneous calcium events and demonstrated that it is necessary for proper myofibrillogenesis in skeletal muscle.

Nolan Campbell Skills

Confocal Microscopy Cell Culture Molecular Biology Viral Vectors Biochemistry Neuroscience Fluorescence Microscopy Rnai Neuropharmacology Recombinant Dna Technology Transfection Biotechnology Immunohistochemistry Microscopy Transgenic Mice Rodent Surgery Two Photon Microscopy Microsoft Office Vector Nti Western Blotting In Vivo Animal Models Pcr Immunoprecipitation Molecular Cloning Immunofluorescence Protein Expression Tissue Culture Scientific Writing Multiple Sclerosis Treatments Optogenetics Chemical And Genetic Calcium Indicators Deconvolution Microscopy Mouse Behavioral Studies Primary Neuronal Culture

Nolan Campbell Education Details

  • Uc San Diego
    Uc San Diego
    Biology
  • University Of Missouri-Kansas City
    University Of Missouri-Kansas City
    Biology

Frequently Asked Questions about Nolan Campbell

What company does Nolan Campbell work for?

Nolan Campbell works for Johnson & Johnson

What is Nolan Campbell's role at the current company?

Nolan Campbell's current role is J&J Medical Director | Leader of Teams and Evidence Generation | Designer of Studies and Analyses | Experience in Medical and Clinical Development | Focus in Neurology, Neuroimmunology, and Neuromuscular Disease.

What is Nolan Campbell's email address?

Nolan Campbell's email address is no****@****gen.com

What schools did Nolan Campbell attend?

Nolan Campbell attended Uc San Diego, University Of Missouri-Kansas City.

What are some of Nolan Campbell's interests?

Nolan Campbell has interest in Skiing, Biotechnology, Opera, Poker, Surfing, Hiking, Camping, Music, Ballet, Theater.

What skills is Nolan Campbell known for?

Nolan Campbell has skills like Confocal Microscopy, Cell Culture, Molecular Biology, Viral Vectors, Biochemistry, Neuroscience, Fluorescence Microscopy, Rnai, Neuropharmacology, Recombinant Dna Technology, Transfection, Biotechnology.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.